Related Experiment Video
Updated: Jul 20, 2025

09:47
Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
Published on: December 15, 2023
1.1K
Untangling Alzheimer's disease with spatial multi-omics: a brief review
Cody R Marshall1,2, Melissa A Farrow2,3, Katerina V Djambazova2,4
1Chemical and Physical Biology Program, Vanderbilt University School of Medicine, Nashville, TN, United States.
Frontiers in Aging Neuroscience
|August 3, 2023
Summary
Spatial omics advances the study of Alzheimer's disease (AD) and related pathologies. These techniques map molecular and cellular organization, offering new insights into AD's complex drivers and potential treatments.
Area of Science:
- Neurology
- Biotechnology
- Systems Biology
Background:
- Alzheimer's disease (AD) is a common dementia characterized by amyloid plaques and neurofibrillary tangles.
- AD-associated pathologies like cerebral amyloid angiopathy (CAA) share molecular drivers with AD, complicating understanding.
- The spatiomolecular relationships within these neurological disorders are poorly understood.
Purpose of the Study:
- To review recent advancements in spatial omics technologies for Alzheimer's disease research.
- To highlight how these methods elucidate the spatial organization of molecular and cellular features in neuropathologies.
- To provide a systems biology perspective on the tissue microenvironment in AD.
Main Methods:
- Profiling and molecular imaging methods within spatial omics.
- Characterizing cell type and tissue feature organization.
- Mapping molecular distributions in brain tissue.
Main Results:
- Spatial omics enables detailed characterization of the relationship between tissue organization and molecular pathology.
- Emerging technologies offer higher resolution and molecular coverage for AD research.
- These methods provide a systems biology view of the neuropathological microenvironment.
Conclusions:
- Spatial omics is crucial for understanding the complex molecular drivers of Alzheimer's disease.
- Advancements in spatial omics open new avenues for AD prediction, diagnosis, and mitigation.
- This approach facilitates a deeper understanding of AD and associated pathologies.
Keywords:
Alzheimer’s diseaseimaging mass spectrometry (IMS)immunoflorescencemass spectrometrymicroscopyneurosciencespatial multi-omicsspatial transcriptomics (ST)
